Finally, the PKA/PKC modulation as a therapeutic approach for other neurodegenerative diseases such as cerebral ischemic/stroke and Alzheimer’s Disease was previously demonstrated31–33. The gene discussed is PRRT2; the disease is neurodegenerative disease.